A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2011
10/05/2011	EP2371843A1 Functional epitopes of streptococcus pneumoniae psaA antigen and uses thereof
10/05/2011	EP2371838A1 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
10/05/2011	EP2371837A1 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
10/05/2011	EP2371836A1 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
10/05/2011	EP2371393A1 Preventive or remedy for inflammatory disease
10/05/2011	EP2371392A1 Calicheamicin derivative-carrier conjugates
10/05/2011	EP2371391A1 Therapeutic use of anti-CS1 antibodies
10/05/2011	EP2371390A2 Antagonists and methods of use therefor
10/05/2011	EP2371389A2 FcgammaRIIB-specific antibodies and methods of use thereof
10/05/2011	EP2371388A2 Antibody formulations
10/05/2011	EP2371387A2 HIV consensus sequence antigens and their use in vaccina
10/05/2011	EP2371386A1 Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs
10/05/2011	EP2371385A1 Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs
10/05/2011	EP2371384A1 Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs
10/05/2011	EP2371383A1 Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs
10/05/2011	EP2371382A1 Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs
10/05/2011	EP2371381A2 Compositions and methods for eliciting an immune response to escape mutants of targeted therapies
10/05/2011	EP2371380A1 MVA expressing modified hiv envelope, gag, and pol genes
10/05/2011	EP2371369A1 EGFR inhibitor and antiviral agent for simultaneous, separate or sequential use in the treatment and/or prevention and/or palliation of cancer
10/05/2011	EP2371353A1 Stabilized pharmaceutical composition, liquid preparation of stabilized pharmaceutical composition, film-form preparation, and method for producing film-form preparation
10/05/2011	EP2370593A2 Methods for the treatment of infections and tumors
10/05/2011	EP2370584A1 Use of micrornas to control virus helper nucleic acids
10/05/2011	EP2370469A2 Anti-rhd monoclonal antibodies
10/05/2011	EP2370468A1 ANTI-cMET ANTIBODY
10/05/2011	EP2370464A1 Process for the modulation of the antagonistic activity of a monoclonal antibody
10/05/2011	EP2370455A2 Virus like particle compositions and methods of use
10/05/2011	EP2370454A1 Wdrpuh epitope peptides and vaccines containing the same
10/05/2011	EP2370175A2 Methods of inhibiting quiescent tumor proliferation
10/05/2011	EP2370102A1 Immunoglobulin g composition
10/05/2011	EP2370101A1 Use of flt3 ligand for strengthening immune responses in rna immunization
10/05/2011	EP2370100A1 Peptide adjuvants
10/05/2011	EP2370099A1 Modified rsv f proteins and methods of their use
10/05/2011	EP2370098A1 Antibodies for guanylyl cyclase receptors
10/05/2011	EP2370097A1 Antitumor combinations containing antibodies recognizing specifically cd38 and cylophosphamide
10/05/2011	EP2370096A1 Antitumor combinations containing antibodies recognizing specifically cd38 and cytarabine
10/05/2011	EP2370095A1 Antitumor combinations containing antibodies recognizing specifically cd38 and vincristine
10/05/2011	EP2370094A1 Antitumor combinations containing antibodies recognizing specifically cd38 and melphalan
10/05/2011	EP2370092A1 Modulation of olfml-3 mediated angiogenesis
10/05/2011	EP2370090A1 Treating neoplasms with neurotoxin
10/05/2011	EP2369936A1 Compositions and methods for the treatment and prevention of lens fibrotic diseases
10/05/2011	EP1844077B1 Dr5 antibodies and uses thereof
10/05/2011	EP1809737B9 Mature dendritic cell compositions and methods for culturing same
10/05/2011	EP1784416B1 Vaccines against aids comprising cmv/r nucleic acid constructs
10/05/2011	EP1738765B1 Antigen-drug vehicle enabling transmucosal and transdermal administration and method of inducing mucosal immunity, mucosal vaccine and dds using the same
10/05/2011	EP1653912B1 Vaccine immunotherapy for immune suppressed patients
10/05/2011	EP1495115B1 Nucleic acid sequence and protein in addition to polypeptides coding for mannitol-dehydrogenases or parts thereof and the production and use thereof in diagnosis and therapy
10/05/2011	EP1492814B1 Interleukin-1-beta derived peptide and its therapeutic application
10/05/2011	EP1490398B1 Tumour associated antigens
10/05/2011	EP1267945B1 Genetically modified cells expressing a tgf-beta inhibitor, the cells being lung cancer cells
10/05/2011	EP1267838B1 Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into a biological environment from a polymer matrix
10/05/2011	EP1246920B1 Prevention of affections associated with porcine circovirus-2
10/05/2011	EP1177203B1 Collagen-binding proteins from enterococcal bacteria
10/05/2011	EP1137777B1 Novel compounds derived from neisseria meningitidis
10/05/2011	CN1946407B Methods and composition for treating tumors and metastatic disease
10/05/2011	CN1717251B Peptide-based passive immunization therapy for treatment of atherosclerosis
10/05/2011	CN1446227B Novel fibroblast growth factor (FRF23) and method for use
10/05/2011	CN102209727A Anti-tgf-beta receptor ii antibodies
10/05/2011	CN102209724A Non-typhoidal salmonella vaccines
10/05/2011	CN102209558A Pharmaceutical composition utilising combinations of variants of the gonadotropin-liberating hormone (gnrh) as immunogen
10/05/2011	CN102209557A Targeting pathogenic monocytes
10/05/2011	CN102209556A 改良的抗cd19抗体 Modified antibodies anti-cd19
10/05/2011	CN102209555A Composition comprising sortase anchored surface proteins of streptococcus uberis
10/05/2011	CN102209530A Orally administrable immunostimulant product for aquaculture
10/05/2011	CN102206679A Shuttle vector of vaccinia virus and its application
10/05/2011	CN102206663A Nucleic acid construct containing full-length genome of human hepatitis C virus and uses
10/05/2011	CN102206642A Double-stranded RNA molecule with mammal body fluid stability, and preparation method and application thereof
10/05/2011	CN102206607A Three genes deleted mutant of enterohemorrhagic escherichia coli O157:H7
10/05/2011	CN102206277A Antibodies that bind human interleukin-18 and methods of making and using
10/05/2011	CN102206276A Humanized antibodies derived from DD-3B6/22, specific for the D-dimer fragment of fibrin
10/05/2011	CN102206275A Anti-tetanotoxin monoclonal neutral antibody, and composition and application thereof
10/05/2011	CN102206258A NmpC subunit vaccine of salmonella paratyphi A and preparation method thereof
10/05/2011	CN102206257A Edwardsiella tarda immunogenic protective antigen, and related expression vector, vaccine and application
10/05/2011	CN102206256A HCV envelope protein E2 with deleting hypervariable region 1 and use thereof
10/05/2011	CN102206255A Sequences of mutants of Tat protein of human immunodeficiency virus type 1 and use thereof
10/05/2011	CN102205131A Preparation method and application of DNA (deoxyribonucleic acid) vaccine of influenza A (H1N1)
10/05/2011	CN102205123A Preparation method of yolk antibody sustained-release preparation for preventing gosling plague
10/05/2011	CN102205122A Method for preparing piglet diarrhea-resisting egg yolk antibody microcapsules by spray drying method
10/05/2011	CN102205121A Stabilized pharmaceutical composition, liquid preparation of stabilized pharmaceutical composition, film-form preparation, and method for producing film-form preparation
10/05/2011	CN102205120A Production method of porcine parvovirus inactivated vaccine
10/05/2011	CN102205119A Inactivated rabies antigen and preparation method thereof
10/05/2011	CN102205118A Biological product and preparation method thereof
10/05/2011	CN102205117A Dairy cow mammitis staphylococcus aureus-Escherichia coli bigeminy polyvalent vaccine and preparation method thereof
10/05/2011	CN102205116A Method for producing vaccine by virtue of culturing animal cells
10/05/2011	CN101816798B Gene vaccine of sperm-specific protein Ropporin and preparation method thereof
10/05/2011	CN101386643B Expression of vibrio alginolyticus outer membrane protein VA0760 and application thereof as vaccine component
10/05/2011	CN101322844B Non-virus non-structural protein foot-and-mouth disease vaccine and preparation thereof
10/05/2011	CN101270361B Japanese blood fluke TSP protein extracellular cyclo-2 encoding gene, polypeptide, amalgamation protein and uses in preparing vaccine
10/05/2011	CN101227919B Peptide-based influenza vaccine formulation
10/05/2011	CN101177684B Sheep brucella M5 strain ribosome protein L7/L12 gene, encoding protein and uses thereof
10/05/2011	CN101163498B Methods and reagents for diagnosing hantavirus infection
10/04/2011	US8030471 Plasmodium malariae and Plasmodium ovale genes and uses thereof
10/04/2011	US8030469 Anti-CD26 antibodies and methods of use thereof
10/04/2011	US8030462 Immunotherapy; induce immunology response
10/04/2011	US8030457 Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)
10/04/2011	US8030456 Nogo receptor antagonists
10/04/2011	US8030450 Canine RANKL and methods for preparing and using the same
10/04/2011	US8030288 Methods for identifying compounds for the treatment of type 1 diabetes
10/04/2011	US8030285 Asthma; ellergy vaccine; antisense therapy; used to treat, prevent, or ameliorate the symptoms resulting from exposure to a bio-warfare agent
10/04/2011	US8030280 Melanoma antigens and their use in diagnostic and therapeutic methods
10/04/2011	US8030067 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof

1 ... 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 ... 1823